<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01613638</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC/10-02 - PENEW</org_study_id>
    <secondary_id>B110827-40</secondary_id>
    <secondary_id>11/22-811</secondary_id>
    <secondary_id>2010-A01445-34</secondary_id>
    <nct_id>NCT01613638</nct_id>
  </id_info>
  <brief_title>Pregnancy Environment and Newborn Malformations</brief_title>
  <acronym>PENEW</acronym>
  <official_title>Congenital Malformations and Intrauterine Pollutants Exposure (Alcohol, Solvents and Pesticides) in Brittany. Population Based Case-control Study Short Title : Malformations and Environment Acronym : PENEW for &quot;Pregnancy Environment and Newborn Malformations&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital malformations rate is about 3% in France. There are already 5 registries in
      France, covering about 16% of French births: Paris Registry, (about 38 000 births /year),
      Alsace Registry, (about 23 000 births/year), Rhône-Alpes Registry, (about 56 000
      births/year), Auvergne Registry, (about 14 000 births/year), and la Réunion Registry. The aim
      of malformation registries is to carry out epidemiologic surveillance of congenital
      anomalies. The objectives are mainly to provide essential epidemiologic information on
      congenital anomalies, to facilitate the early warning of teratogenic exposures, to act as an
      information and resource centre regarding clusters, to provide data for research related to
      the causes and prevention of congenital anomalies.

      A previous study was carried out in Brittany in 2008-2009, by the perinatal network of Ille
      et Vilaine, in collaboration with two research teams (Inserm U1085 and Inserm U 936), to
      record all cases of 4 types of congenital anomalies: congenital heart disease, spina bifida,
      diaphragmatic hernia and hypospadia. The results showed prevalence rates similar to those
      observed by Eurocat for spina bifida and diaphragmatic hernia, but a higher prevalence
      regarding congenital heart diseases and hypospadia. In this study the investigators could not
      determine whether this was due to a real higher frequency or to a particular exhaustiveness
      in the recording methodology.

      There are hypothesis about the role of intrauterine exposure to pesticides, known as
      endocrine disruptors, and the risk of congenital genital anomalies. Brittany is an intensive
      agricultural area, and it is thus worth studying the impact of pesticides exposure on
      congenital anomalies.

      There are also hypothesis on the impact of occupational exposure to solvents on congenital
      anomalies (Garlantezec 2009), and on the role of alcohol exposure (which concerns about 8%
      pregnant women in France) on oro-facial clefts and congenital heart diseases.

      The Registry of congenital anomalies in Brittany was set up in 2010. The main aim is to study
      the impact of intra-uterine exposure to solvents, pesticides and alcohol on the risk of
      congenital malformations diagnosed at births, by measuring the exposure both directly in
      meconium, and indirectly by questionnaires.

      Secondary objectives are to study other risk factors such as medicine intake, pregnancy
      illness…
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Population based case-control study:

      2 controls per case will be included, corresponding to the first 2 births without congenital
      anomalies, with same sex and same birth place, following the case.

      INVESTIGATION METHODOLOGY :

      All maternity in Brittany were proposed to participate. In each maternity, the referent
      practitioner informs the parents and includes the cases.

      For each case and control, meconium samples and a mother's lock are collected by nurses or
      midwives, medical data are collected from medical reports by the registry investigator, and a
      self-questionnaire is filled by the mother.

      Meconium samples are immediately stored in a freezer (-20°C), secondarily transported to a
      biological storage centre at the university hospital and then dispatched to specialised
      laboratories for toxicological analyses: INERIS (for solvents and pesticides) and Toxicology
      Unit, University hospital Rennes (for Alcohol).

      For dead fetuses (stillbirths or termination of pregnancy), meconium will be collected by the
      pathologist in charge of the autopsy, after parents' consent.

      Evaluation of exposure:

        -  direct evaluation: by toxicological analyses in meconium samples: Alcohol, Solvents and
           pesticides

        -  indirect evaluation: by maternal self-questionnaire including data on occupational and
           domestic exposures, hobbies, life habits…, precise address (for spatial location)

      Particular cases: mild congenital heart defects, genital anomalies and hip dislocation
      diagnosed later after birth (after the period oh meconium and before the age of one): these
      cases will be spotted through the Registry, there won't be any biological sample for them,
      but mothers will be contacted by main investigator and medical data and mother questionnaires
      will be collected. There won't be any control included for those cases included after birth.

      Associations between exposure risk factors (alcohol, solvents and pesticides) and the risk of
      congenital malformations will be estimated by a multivariate analysis.

        -  Exposure to solvents will be estimated by assay in meconium and by occupational
           questionnaire

        -  Exposure to alcohol will be estimated by assay of Ethylglucuronide et de Ethylsulfate in
           meconium.

        -  Exposure to pesticides will be estimated by assay in meconium, by questionnaire and by
           spatial location.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>impact of intra-uterine exposure to solvents, pesticides and alcohol on the risk of congenital malformations diagnosed at births, by measuring the exposure both directly in meconium, and indirectly by questionnaires.</measure>
    <time_frame>up to 48 hours</time_frame>
    <description>impact of intra-uterine exposure to solvents, pesticides and alcohol on the risk of congenital malformations diagnosed at births, by measuring the exposure both directly in meconium, and indirectly by questionnaires.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>other risk factors such as medicine intake, pregnancy illness…</measure>
    <time_frame>up to 48 hours</time_frame>
    <description>other risk factors such as medicine intake, pregnancy illness…</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Congenital Malformation</condition>
  <arm_group>
    <arm_group_label>Congenital malformations</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All livebirths, fetal deaths with gestational age (GA) ≥22 weeks and terminations of pregnancy (at any gestational age) after prenatal diagnosis of malformation.
born from mothers living in Brittany at delivery
with a congenital anomaly according to Eurocat criteria, diagnosed or suspected (and then confirmed) at birth
or with mild congenital heart defects, genital anomalies or hip dislocation diagnosed after birth (and before the age of one)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>2 controls per case will be included, corresponding to the first 2 births without congenital anomalies, with same sex and same birth place, following the case.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>meconium samples + maternal self-questionnaire</intervention_name>
    <description>meconium samples + maternal self-questionnaire</description>
    <arm_group_label>Congenital malformations</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All live births, fetal deaths with gestational age (GA) ≥22 weeks and terminations of
        pregnancy (at any gestational age) after prenatal diagnosis of malformation.

          -  born from mothers living in Brittany at delivery

          -  with a congenital anomaly according to Eurocat criteria, diagnosed or suspected (and
             then confirmed) at birth

          -  or with mild congenital heart defects, genital anomalies or hip dislocation diagnosed
             after birth (and before the age of one)

        Non inclusion criteria :

          -  Spontaneous abortion before 22 weeks gestational age.

          -  Mother with legal protection (guardianship)

        Exclusion Criteria:

          -  Prenatally suspected malformations, which are not confirmed by postnatal screening or
             clinical evolution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence Rouget, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Lefevre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fougères Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joëlle Gueguen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint-Grégoire Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle Blanchot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique La Sagesse - Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Vernis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint-Malo Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique Chaumet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vitré Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Abi-Fadel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Redon Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Rebour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lannion Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Turban, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dinan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claire Combescure, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint-Brieuc Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Magagi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Polyclinique du Littoral - Saint-Brieuc</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Collet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Brest</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Somerville, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Polyclinique de Keraudren - Brest</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alain Hassoun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Pasteur - Brest</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charles Bellot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Quimper Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Tillaut, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lorient Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hubert Journel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vannes Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claire Duhaut, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Océane - Vannes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Vallée, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontivy Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Agnès Guillou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ploermël Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florence Rouget, MD</last_name>
    <email>florence.rouget@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Brest</city>
        <state>Brittany</state>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Polyclinique de Keraudren</name>
      <address>
        <city>Brest</city>
        <state>Brittany</state>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Brest University Hospital</name>
      <address>
        <city>Brest</city>
        <state>Brittany</state>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Collet, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michel Collet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Parent, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques Sizun, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascale Marcorelles, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dinan Hospital</name>
      <address>
        <city>Dinan</city>
        <state>Brittany</state>
        <zip>22101</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Fougères Hospital</name>
      <address>
        <city>Fougères</city>
        <state>Brittany</state>
        <zip>35300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Lannion Hospital</name>
      <address>
        <city>Lannion</city>
        <state>Brittany</state>
        <zip>22303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Lorient Hospital</name>
      <address>
        <city>Lorient</city>
        <state>Brittany</state>
        <zip>56322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Ploermel Hospital</name>
      <address>
        <city>Ploermel</city>
        <state>Brittany</state>
        <zip>56804</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Agnès Guillou, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie-Agnès Guillou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Paule Thomas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pontivy Hospital</name>
      <address>
        <city>Pontivy</city>
        <state>Brittany</state>
        <zip>56306</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Quimper Hospital</name>
      <address>
        <city>Quimper</city>
        <state>Brittany</state>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Redon Hospital</name>
      <address>
        <city>Redon</city>
        <state>Brittany</state>
        <zip>35603</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Clinique La sagesse</name>
      <address>
        <city>Rennes</city>
        <state>Brittany</state>
        <zip>35043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <state>Brittany</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence Rouget, MD</last_name>
    </contact>
    <investigator>
      <last_name>Florence Rouget, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Pladys, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrice Poulain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent Pasquier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edouard Habonimana, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Loget, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Brieuc Hospital</name>
      <address>
        <city>Saint-Brieuc</city>
        <state>Brittany</state>
        <zip>22000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Combescure, MD</last_name>
    </contact>
    <investigator>
      <last_name>Claire Combescure, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Baptiste Muller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique du Littoral</name>
      <address>
        <city>Saint-Brieuc</city>
        <state>Brittany</state>
        <zip>22003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Saint-Grégoire Hospital</name>
      <address>
        <city>Saint-Grégoire</city>
        <state>Brittany</state>
        <zip>35760</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joëlle Gueguen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Joëlle Gueguen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Malo Hospital</name>
      <address>
        <city>Saint-Malo</city>
        <state>Brittany</state>
        <zip>35400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Clinique Océane</name>
      <address>
        <city>Vannes</city>
        <state>Brittany</state>
        <zip>56000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Vannes Hospital</name>
      <address>
        <city>Vannes</city>
        <state>Brittany</state>
        <zip>56000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Vitré Hospital</name>
      <address>
        <city>Vitré</city>
        <state>Brittany</state>
        <zip>35506</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2012</study_first_submitted>
  <study_first_submitted_qc>June 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2012</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>congenital malformation</keyword>
  <keyword>pollutants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

